Social cognition across bipolar disorder and behavioral variant frontotemporal dementia: an exploratory study.


Journal

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
ISSN: 1809-452X
Titre abrégé: Braz J Psychiatry
Pays: Brazil
ID NLM: 100895975

Informations de publication

Date de publication:
11 May 2023
Historique:
received: 27 10 2022
accepted: 03 01 2023
medline: 15 5 2023
pubmed: 8 2 2023
entrez: 7 2 2023
Statut: epublish

Résumé

Bipolar disorder type 1 (BD1) and behavioral-variant frontotemporal dementia (bvFTD) share similar behavioral and cognitive symptoms, rendering the differential diagnosis between them a clinical challenge. We investigated the accuracy of social cognition (SC) measures to differentiate bvFTD from BD. We included three groups of participants: early-onset BD1 (in remission, n=20), bvFTD (n=18), and cognitively healthy controls (HC) (n=40), matched for age, schooling, and sex. All participants underwent cognitive assessment, including the Facial Emotion Recognition (FER) and Modified Faux-Pas (mFP) tests, which assess mentalizing. Compared to HC, BD1 and bvFTD patients underperformed on both SC measures. BD1 and bvFTD did not differ regarding FER or mFP total scores, although patients with bvFTD had significantly higher difficulties than those in the BD1 group to detect social faux-pas (p < 0.001, d = 1.35). BD1 and bvFTD share deficits in the core SC functions. These findings should be considered in the development of tasks aiming to improve clinical differentiation between the two disorders.

Identifiants

pubmed: 36749822
doi: 10.47626/1516-4446-2022-2935
pmc: PMC10154010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-136

Subventions

Organisme : Conselho Nacional de Pesquisa Científica
ID : 402853/2012
Pays : Brazil

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Auteurs

Izabela Guimarães Barbosa (IG)

Departamento de Saúde Mental, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil. Programa de Pós-Graduação em Neurociências, UFMG, Belo Horizonte, MG, Brazil.

Flávia da Mata Chiácchio Leite (FDMC)

Serviço de Psiquiatria, Instituto da Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, MG, Brazil.

Maxime Bertoux (M)

Lille Neuroscience & Cognition, Inserm, CHU Lille, U1172, Université de Lille, Lille, France. Development of Innovative Strategies for a Transdisciplinary Approach to ALZheimer's Disease, Lille Centre of Excellence for Neurodegenerative Disorders, Lille, France.

Henrique Cerqueira Guimarães (HC)

Grupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina, UFMG, Belo Horizonte, MG, Brazil.

Luciano Inácio Mariano (LI)

Programa de Pós-Graduação em Neurociências, UFMG, Belo Horizonte, MG, Brazil. Grupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina, UFMG, Belo Horizonte, MG, Brazil.

Leandro Boson Gambogi (LB)

Programa de Pós-Graduação em Neurociências, UFMG, Belo Horizonte, MG, Brazil. Grupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina, UFMG, Belo Horizonte, MG, Brazil.

Antônio Lúcio Teixeira (AL)

Instituto de Ensino e Pesquisa Santa Casa BH, Belo Horizonte, MG, Brazil. Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Paulo Caramelli (P)

Programa de Pós-Graduação em Neurociências, UFMG, Belo Horizonte, MG, Brazil. Grupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina, UFMG, Belo Horizonte, MG, Brazil. Departamento de Clínica Médica, Faculdade de Medicina, UFMG, Belo Horizonte, MG, Brazil.

Leonardo Cruz de Souza (LC)

Programa de Pós-Graduação em Neurociências, UFMG, Belo Horizonte, MG, Brazil. Grupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina, UFMG, Belo Horizonte, MG, Brazil. Departamento de Clínica Médica, Faculdade de Medicina, UFMG, Belo Horizonte, MG, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH